Profile
ADVB DHR-PB TMO DHR IDXX A
Company Name Advanced Biomed Inc. Common Stock Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $9.96M $916.76B $210.04B $154.09B $57.77B $40.65B
Employees 0.04K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Yi Lu Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
ADVB DHR-PB TMO DHR IDXX A
Quant Rating Score 1 5 3 3 3 3
Quant Rating Strong Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
ADVB DHR-PB TMO DHR IDXX A
Last Close $0.4428 $1261.26 $565.24 $213.83 $722.12 $146.08
High 52 $4 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 - $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -88.93 % 0 % -6.84 % -14.67 % -0.11 % -4.27 %
Price vs. 52 Week Low 0 % 0 % 44.86 % 22.44 % 100.01 % 47.12 %
Total Return
ADVB DHR-PB TMO DHR IDXX A
1 Month Return -8.38 % 0 % 4.03 % -0.54 % 14.41 % 3.13 %
3 Month Return 22.32 % 0 % 21.07 % 7.33 % 12.49 % 27.15 %
6 Month Return -76.82 % 0 % 33.75 % 8.32 % 51.99 % 34.8 %
9 Month Return 0 % 0 % -2.94 % 0.8 % 54.12 % -1.29 %
YTD Return 0 % 0 % 8.65 % -6.85 % 74.66 % 8.74 %
1 Year Return 0 % 0 % 0.79 % -14.49 % 73.59 % 4.04 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ADVB DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.57 % 0.3 % 0.57 % - 0.69 %
Dividend Paid and Capex Coverage Ration (TTM) -103.18 % 2.94 % 3.54 % 2.94 % 8.09 % 4.01 %
Dividend Per Share (TTM) - 1.23 % 1.68 % 1.23 % - 0.99 %
Payout Ratio (TTM) - 24.18 % 9.48 % 24.18 % - 22.95 %
Growth
ADVB DHR-PB TMO DHR IDXX A
Asset Growth 145908.57 % -8.22 % 1.03 %
Gross Profit Growth 14.65 % 1.23 % 8.63 %
Revenue Growth - -0.06 % 6.46 %
Revenue 3 Year - -20.76 % 25.23 %
Revenue 5 Year - 30.38 % 69.09 %
Revenue 10 Year - 15.17 % 218.38 %
EBIT Growth 96.01 % -7.67 % 3.47 %
Net Income Growth 96.35 % -18.16 % 5.07 %
Net Income 3 Yeari Growth Per Share 98.35 % -40.75 % 23.15 %
Net Income 5 Yeari Growth Per Share 97.07 % 49.13 % 116.76 %
Net Income 10 Yeari Growth Per Share 97.07 % 44.14 % 492.42 %
Operating Income Growth 96.3 % -1.8 % 2.84 %
Operating Cash Flow Growth (CFG) 91.47 % -6.64 % 2.48 %
Operating 3 Year CFG 83.96 % -21.78 % 27.03 %
Operating 5 Year CFG 79.72 % 65.54 % 111.28 %
Operating 10 Year CFG 79.72 % 70.94 % 378.1 %
EPS Growth 96.64 % -17.24 % 5.9 %
EPS Diluted Growth 96.64 % -17.08 % 6.06 %
Book Value Per Share 193136.09 % -6.67 % 8.24 %
Share Holder 3 Year Equity Growth Per Share 65177.27 % 7.23 % 138.87 %
Share Holder 5 Year Equity Growth Per Share 188577.79 % 60.08 % 838.67 %
Share Holder 10 Year Equity Growth Per Share 188577.79 % 103.57 % 1547.69 %
Dividend Per Share Growth - -5.75 % -
Dividend 3 Year Growth Per Share - 1.18 % -
Dividend 5 Year Growth Per Share - 42.62 % -
Dividend 10 Year Growth Per Share - 224 % -
Debt Growth -65.84 % -12.23 % -7.53 %
Free Cash Flow Growth 91.71 % -8.39 % 3.26 %
Updated On 30 Jun 2025 31 Dec 2024 31 Dec 2024
Profitability
ADVB DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM - 61.37 % 39.81 % 61.37 % 61.72 % 52.96 %
Return on Assets TTM -1157.34 % 4.38 % 6.38 % 4.38 % 30.34 % 9.98 %
Return on Equity TTM -173.11 % 6.88 % 13.11 % 6.88 % 67.78 % 19.97 %
Return on Capital Employed TTM -1569.34 % 7.31 % 9.04 % 7.31 % 61.18 % 13.97 %
Net Income Per EBT TTM 100 % 83.9 % 92.29 % 83.9 % 80.67 % 87.52 %
EBT Per Ebit TTM 132.55 % 77.59 % 89.34 % 77.59 % 97.51 % 96.54 %
EBIT Per Revenue TTM - 22.17 % 18.22 % 22.17 % 31.34 % 21.27 %
Cash Flow To Debt Ratio TTM -2386.67 % 37.48 % 21.44 % 37.48 % 424.21 % 43.85 %
Receivables Turnover TTM - 6.46 4.91 6.46 7.35 4.91
Payables Turnover TTM 0.49 5.52 8.83 5.52 13.05 6.02
Inventory Turnover TTM - 3.51 4.58 3.51 4.07 3.15
Fixed Asset Turnover TTM - 451.41 % 429.75 % 451.41 % 563.59 % 345.27 %
Asset Turnover TTM - 30.37 % 42.45 % 30.37 % 123.05 % 55.52 %
Operating Cash Flow Per Share TTM -0.05 8.89 20.24 8.89 13.58 5.25
Free Cash Flow Per Share TTM -0.05 7.06 16.17 7.06 11.91 4.92
Cash Per Share TTM 0.46 % 215 % 938.1 % 215 % 259.9 % 538.6 %
Operating Cash Flow Sales Ratio TTM - 26.03 % 17.49 % 26.03 % 26.11 % 22.02 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.97 % 79.41 % 79.87 % 79.41 % 87.64 % 93.78 %
Cash Flow Coverage Ratios TTM -2386.67 % 37.48 % 21.44 % 37.48 % 424.21 % 43.85 %
Price To Free Cash Flows Ratio TTM -9.55 30.57 34.37 30.71 60.59 28.99
Price To Operating Cash Flows Ratio TTM -9.64 24.08 27.48 24.19 53.16 27.33
Price Cash Flow Ratio TTM -9.64 24.08 27.48 24.19 53.16 27.33
Income Statement (TTM)
ADVB DHR-PB TMO DHR IDXX A
Revenue $0B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $-0B $14.21B $17.73B $14.21B $2.38B $3.54B
Gross Profit Ratio 0% 59.5% 41.34% 59.5% 61.04% 54.3%
EBITDA $-0B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted - 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
ADVB DHR-PB TMO DHR IDXX A
Long Term Debt $0B $16.47B $30.3B $16.47B $0.55B $3.49B
Total Liabilities $3.03B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $3.48B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $1.82B $2.12B $1.82B $0.06B $0.18B
Total Debt $0B $17.15B $32.78B $17.15B $0.99B $3.57B
Total Assets $6.51B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
ADVB DHR-PB TMO DHR IDXX A
Net Income $-3.26B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $-0.03B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 146.77
ACRS Aclaris Therapeutics, Inc. 2.26
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 8.6
BIAF bioAffinity Technologies, Inc. 2.17
BIAFW bioAffinity Technologies, Inc. 0.35
BIOC Biocept, Inc. 0.4349
BNBX Stader BNB 3.46
BNGO Bionano Genomics, Inc. 1.69
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 12.2
CDNA CareDx, Inc 16.53
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.35
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 167.7
CSTL Castle Biosciences, Inc. 33.57
Unlock